Although hyperglycemia and diabetes can be a potential risk factor for retinal neovascularization, our findings did not indicate an additive or synergistic effect between high glucose and Roxadustat in VEGF secretion in ARPE-19 cells. The gene discussed is VEGFA; the disease is diabetes mellitus.